guardanthealth.com (GH): Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan

Guardant Health - logo grafis emiten GH

The EV/EBITDA valuation trend reflects the volatility of Guardant Health, Inc. (GH), which is burdened by debt and a lack of profitability amid its struggle for FDA approval. The business is currently transforming its strategy, shifting from recurrence monitoring to mass early screening. Meanwhile, the 0.00 metric indicates the maturity status of the asset, which strictly adheres to environmental regulations for biomaterial disposal.

GH (Guardant360) riwayat Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan saka 23.11.2025 nganti 10.11.2026

Rincian analitis perusahaan Guardant Health, Inc.

- rega saiki lan proyeksi nilai saham:
Rega saham Guardant360|GH - Prakiraan konsensus analis
- data kapitalisasi bursa:
Nilai pasar Guardant Corp|GH - Nilai Total Perusahaan
- indikator nilai buku ekuitas:
Nilai Akuntansi saben Saham Guardant Health|GH - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku guardanthealth.com|GH - Gunggung Aset Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Total Utang marang Modal Guardant Health, Inc.|GH - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Guardant Health|GH - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku Guardant Corp|GH - Tanggungan jangka dawa|Kewajiban jangka cendhak perusahaan Guardant Health|Rasio cepet guardanthealth.com
- indikator pendapatan resik lan kelipatan nilai:
GH - Bathi resik|Bathi sing dikarepake Guardant Health, Inc.|GH - Nilai perusahaan marang bathi resik|Pangali Forward P/E Guardant Health, Inc.|GH - Rasio P/E diaturake wutah|Pangali EV/EBITDA Guardant Corp|GH - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Guardant Health|GH - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan guardanthealth.com|GH - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Guardant Health, Inc.
Analisis komprehensif perusahaan:Guardant360 GH
Sampel barang Guardant Health

This indicator measures the total enterprise value including net debt relative to operating profit, allowing for an assessment of the real value of assets without the influence of tax distortions. By analyzing the business valuation level via the EV/EBITDA multiple on the GURU.Markets platform, an investor can see the financing efficiency of Guardant Health (GH) in developing liquid biopsy for cancer diagnostics and clinical research for biopharmaceutical companies.

Pesaing utama

Pangali EV/EBITDA CAI (Caris)|Pangali EV/EBITDA Veracyte Diagnostics VCYT|CELC - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|GRAL: Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|MYGN (Myriad Genetics) - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Castle Biosciences Inc (CSTL)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Burning Rock Biotech Ltd.|VolitionRx Ltd (VNRX) - Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA BDSX|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan precipiodx.com|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Check-Cap CHEK|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan mainzbiomed.com (MYNZ)|OncoCyte Corp. - Pangali EV/EBITDA